Publications
Some of our publications over the last few years:
- Schnepp BC, Jensen RL, Chen C-L, Johnson PR, and Clark KR. Characterization of Adeno-Associated Virus Genomes Isolated from Human Tissues. J Virol., 2005 Dec;79(23):14793-803
- Chen C-L, Jensen RL, Schnepp BC, Connell MJ, Shell R, Sferra TJ, Bartlett JS, Clark KR, and Johnson PR. Molecular Characterization of Adeno-Associated Viruses infecting Children. J Virol., 2005 Dec;79(23):14781-92
- HIV Vaccine Design: Insights from Live Attenuated SIV Vaccines. Koff WC, Johnson PR, Watkins DI, Burton DR, Lifson JD, Hasenkrug K, McDermott AB, Schultz A, Zamb TJ, Boyle r, and Desrosiers RC. Nature Immunology, 2006 Jan;7(1):19-23
- Johnston RE, Johnson PR, Connell MJ, Montefiori DC, West A, Collier ML, Cecil C, Swanstrom R, Frelinger JA, Davis NL. Vaccination of macaques with SIV immunogens delivered by Venezuelan equine encephalitis virus replicon particle vectors followed by a mucosal challenge with SIVsmE660. Vaccine 23:4969-79, 2005.
- Johnson PR, Schnepp BC, Connell MJ, Rohne D, Robinson S, Krivulka GR, Lord CI, Zinn R, Montefiori DC, Letvin NL, and Clark KR. Novel Adeno-associated Virus Vector Vaccine Restricts Replication of Simian Immunodeficiency Virus in Macaques. J Virol. 79:955-65, 2005.
- Rybarczyk BJ, Montefiori D, Johnson PR, West A, Johnston RE, Swanstrom R. Correlation between env V1/V2 region diversification and neutralizing antibodies during primary infection by simian immunodeficiency virus sm in rhesus macaques. J Virol. 78:3561-71, 2004
- Haigwood NL, Montefiori DC, Sutton WF, McClure J, Watson AJ, Voss G, Hirsch VM, Richardson BA, Letvin NL, Hu SL, Johnson PR. Passive immunotherapy in simian immunodeficiency virus-infected macaques accelerates the development of neutralizing antibodies. J Virol. 78:5983-95, 2004.
- Burton DR, Desrosiers RC, Johnson PR, Koff WC. An AIDS vaccine: no time to give up. Lancet 364:1938, 2004.
- Schnepp BC, Klemanski DL, Pacak CA, Clark KR, and Johnson PR. Genetic Fate of Recombinant Adeno-Associated Virus Vector Genomes in Muscle. J Virol. 77:3349–350, 2003.
- Lewis AD, Chen R, Montefiori DC, Johnson PR, and Clark KR. Generation of Serum Neutralizing Activity Against HIV-1 by Antibody Gene Transfer. J Virol. 76:8769-75, 2002.
- Clark KR and Johnson PR. Gene delivery of vaccines for infectious diseases. Current Opinion in Molecular Therapeutics. 3:375-384, 2001
- Liu X, Voulgaropoulou F, Chen R, Johnson PR, and Clark KR. Selective rep-cap gene amplification as a mechanism for high-titer recombinant AAV production from stable cell lines. Molecular Therapy 2:394-403, 2000.
- Beall CJ, Phipps AJ, Mathes LE, Stromberg P, and Johnson PR. Transfer of the feline erythropoietin gene to cats using a recombinant adeno-associated virus vector. Gene Therapy 7:534-539, 2000.
- Sferra TJ, Qu G, McNeely D, Rennard R, Clark KR, Lo WD, and Johnson PR. Recombinant adeno-associated virus-mediated correction of lysosomal storage within the central nervous system of the adult MPS VII mouse. Human Gene Therapy 11: 507-519, 2000.